Hari V. Kalluri

469 total citations
15 papers, 330 citations indexed

About

Hari V. Kalluri is a scholar working on Pediatrics, Perinatology and Child Health, Public Health, Environmental and Occupational Health and Psychiatry and Mental health. According to data from OpenAlex, Hari V. Kalluri has authored 15 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pediatrics, Perinatology and Child Health, 5 papers in Public Health, Environmental and Occupational Health and 4 papers in Psychiatry and Mental health. Recurrent topics in Hari V. Kalluri's work include Renal Transplantation Outcomes and Treatments (3 papers), Opioid Use Disorder Treatment (3 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Hari V. Kalluri is often cited by papers focused on Renal Transplantation Outcomes and Treatments (3 papers), Opioid Use Disorder Treatment (3 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Hari V. Kalluri collaborates with scholars based in United States, China and Egypt. Hari V. Kalluri's co-authors include Raman Venkataramanan, Steve N. Caritis, Hongfei Zhang, Merçé Boada, Hana Florian, Hui Zheng, Deli Wang, Michael Gold, Michael England and Steven E. Arnold and has published in prestigious journals such as Brain, Annals of Neurology and American Journal of Obstetrics and Gynecology.

In The Last Decade

Hari V. Kalluri

15 papers receiving 322 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hari V. Kalluri United States 9 115 108 64 41 36 15 330
Shean‐Sheng Wang United States 12 214 1.9× 70 0.6× 35 0.5× 55 1.3× 16 0.4× 17 498
René Bouw United Kingdom 9 94 0.8× 23 0.2× 33 0.5× 49 1.2× 35 1.0× 10 332
Katalin Tóth Hungary 15 143 1.2× 21 0.2× 25 0.4× 42 1.0× 16 0.4× 44 540
Paola Arnold Germany 10 19 0.2× 34 0.3× 61 1.0× 9 0.2× 51 1.4× 21 398
Ádám Kiss Hungary 12 120 1.0× 20 0.2× 10 0.2× 32 0.8× 9 0.3× 19 328
Pei‐Hsuan Weng Taiwan 6 12 0.1× 34 0.3× 66 1.0× 26 0.6× 32 0.9× 9 285
Risa Takayanagi Japan 12 31 0.3× 31 0.3× 46 0.7× 27 0.7× 33 0.9× 57 362
Inga Peter United States 12 73 0.6× 18 0.2× 51 0.8× 19 0.5× 21 0.6× 17 374
Svetlana Dimova Belgium 11 187 1.6× 19 0.2× 71 1.1× 46 1.1× 15 0.4× 34 421
Louis Dumont Canada 11 31 0.3× 13 0.1× 57 0.9× 38 0.9× 29 0.8× 50 489

Countries citing papers authored by Hari V. Kalluri

Since Specialization
Citations

This map shows the geographic impact of Hari V. Kalluri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hari V. Kalluri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hari V. Kalluri more than expected).

Fields of papers citing papers by Hari V. Kalluri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hari V. Kalluri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hari V. Kalluri. The network helps show where Hari V. Kalluri may publish in the future.

Co-authorship network of co-authors of Hari V. Kalluri

This figure shows the co-authorship network connecting the top 25 collaborators of Hari V. Kalluri. A scholar is included among the top collaborators of Hari V. Kalluri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hari V. Kalluri. Hari V. Kalluri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Florian, Hana, Deli Wang, Steven E. Arnold, et al.. (2023). Tilavonemab in early Alzheimer’s disease: results from a phase 2, randomized, double-blind study. Brain. 146(6). 2275–2284. 74 indexed citations
2.
Yeung, Paul, Robert Riesenberg, Amelia Orejudos, et al.. (2023). Cariprazine in Pediatric Patients with Autism Spectrum Disorder: Results of a Pharmacokinetic, Safety and Tolerability Study. Journal of Child and Adolescent Psychopharmacology. 33(6). 232–242. 4 indexed citations
3.
Yeung, Paul, Robert Riesenberg, Amelia Orejudos, et al.. (2022). 3.39 Safety, Tolerability, and Pharmacokinetics of Cariprazine in Pediatric Patients With ASD. Journal of the American Academy of Child & Adolescent Psychiatry. 61(10). S240–S240. 1 indexed citations
4.
Kalluri, Hari V., et al.. (2022). Phase 1 Evaluation of Elezanumab (Anti–Repulsive Guidance Molecule A Monoclonal Antibody) in Healthy and Multiple Sclerosis Participants. Annals of Neurology. 93(2). 285–296. 20 indexed citations
5.
Kalluri, Hari V., Puneet Sood, Wenchen Zhao, et al.. (2020). Evaluation of Renal Anionic Secretion Following Living-donor and Deceased-donor Renal Transplantation: A Clinical Pharmacokinetic Study of Cefoxitin Microdosing. Transplantation Direct. 6(6). e561–e561. 1 indexed citations
6.
Wei, Lai, Guiqiang Wang, Negar Niki Alami, et al.. (2020). Glecaprevir–pibrentasvir to treat chronic hepatitis C virus infection in Asia: two multicentre, phase 3 studies—a randomised, double-blind study (VOYAGE-1) and an open-label, single-arm study (VOYAGE-2). ˜The œLancet. Gastroenterology & hepatology. 5(9). 839–849. 30 indexed citations
7.
Kalluri, Hari V., Ryota Kikuchi, Jeffrey M. Schmidt, et al.. (2020). Coproporphyrin I Can Serve as an Endogenous Biomarker for OATP1B1 Inhibition: Assessment Using a Glecaprevir/Pibrentasvir Clinical Study. Clinical and Translational Science. 14(1). 373–381. 23 indexed citations
8.
Rosebraugh, Matthew, et al.. (2019). Levodopa‐carbidopa intestinal gel high concentration formulation is clinically bioequivalent to commercial formulation. Pharmacology Research & Perspectives. 7(2). e00473–e00473. 3 indexed citations
9.
Kalluri, Hari V., et al.. (2018). Gestational changes in buprenorphine exposure: A physiologically‐based pharmacokinetic analysis. British Journal of Clinical Pharmacology. 84(9). 2075–2087. 31 indexed citations
10.
Caritis, Steve N., et al.. (2017). An evidence-based recommendation to increase the dosing frequency of buprenorphine during pregnancy. American Journal of Obstetrics and Gynecology. 217(4). 459.e1–459.e6. 50 indexed citations
11.
Kalluri, Hari V., Hongfei Zhang, Steve N. Caritis, & Raman Venkataramanan. (2017). A physiologically based pharmacokinetic modelling approach to predict buprenorphine pharmacokinetics following intravenous and sublingual administration. British Journal of Clinical Pharmacology. 83(11). 2458–2473. 24 indexed citations
12.
Kalluri, Hari V., M. Shullo, Heather Johnson, et al.. (2017). Low vitamin D exposure is associated with higher risk of infection in renal transplant recipients. Clinical Transplantation. 31(5). e12955–e12955. 15 indexed citations
13.
14.
Kalluri, Hari V., et al.. (2016). 886: ALTERED ACYCLOVIR PHARMACOKINETICS: A PHYSIOLOGICALLY BASED PHARMACOKINETIC APPROACH. Critical Care Medicine. 44(12). 297–297. 1 indexed citations
15.
Kalluri, Hari V.. (2012). Current state of renal transplant immunosuppression: Present and future. World Journal of Transplantation. 2(4). 51–51. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shean‐Sheng Wang Breakdown of academic impact, for papers by René Bouw Breakdown of academic impact, for papers by Katalin Tóth Breakdown of academic impact, for papers by Paola Arnold Breakdown of academic impact, for papers by Ádám Kiss Breakdown of academic impact, for papers by Pei‐Hsuan Weng Breakdown of academic impact, for papers by Risa Takayanagi Breakdown of academic impact, for papers by Inga Peter Breakdown of academic impact, for papers by Svetlana Dimova Breakdown of academic impact, for papers by Louis Dumont
Rankless by CCL
2026